Please Wait.....
Report
Hemoglobinopathies Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
Market Report I 2023-05-29 I 143 Pages I IMARC Group
The global hemoglobinopathies market size reached US$ 9.2 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 16.3 Billion by 2028, exhibiting a growth rate (CAGR) of 9.39% during 2023-2028.
Hemoglobinopathies is genetic blood disorder that causes structural and production abnormalities in hemoglobin molecules. Sickle cell, thalassemia, hemoglobin C, and beta-thalassemia are some of the common types of hemoglobinopathies. Hemoglobinopathies are detected by genetic testing, hemoglobin by high-performance liquid chromatography, routine red blood cell (RBC) count, hemoglobin isoelectric focusing (Hb IEF), and hemoglobin electrophoresis (Hb ELP) test. Pale skin, shortness of breath, cold hands or feet, tiredness, pain, and swelling in the hands and feet are a few of the most common symptoms hemoglobinopathies. Some of the widely used hemoglobinopathies treatment solutions include antibiotics, ACE inhibitors, stem-cell transplantation, blood transfusions, hydroxyurea, and analgesic.
Hemoglobinopathies Market Trends:
The increasing prevalence of various medical conditions, such as sickle cell disease (SCD) and thalassemia, is one of the key factors driving the growth of the market. Hemoglobinopathies are caused by abnormal hemoglobin that deforms and damages red blood cells and makes them hard and sticky. In line with this, the rising prevalence of anemia, especially among the geriatric population, which is also susceptible to various other chronic ailments, is favoring the market growth. Various technological advancements, such as the development of CRISPR-Cas9 technology to cure hemoglobinopathies by editing, removing, adding, or altering genes and modifying the DNA, are providing an impetus to the market growth. In line with this, the widespread adoption of gene therapy for the treatment of hemoglobinopathy is favoring market growth. Other factors, such as the significant expansion in the healthcare industry, along with the implementation of various government initiatives to promote research and development (R&D) activities to introduce novel therapies for treating hemoglobinopathies at affordable costs is anticipated to provide a positive outlook for the market.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global hemoglobinopathies market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on type, treatment, test type and end user.
Breakup by Type:
Thalassemia
Alpha Thalassemia
Beta Thalassemia
Sickle Cell Disease
Others
Breakup by Treatment:
Hemoglobinopathies Market Trends:
The increasing prevalence of various medical conditions, such as sickle cell disease (SCD) and thalassemia, is one of the key factors driving the growth of the market. Hemoglobinopathies are caused by abnormal hemoglobin that deforms and damages red blood cells and makes them hard and sticky. In line with this, the rising prevalence of anemia, especially among the geriatric population, which is also susceptible to various other chronic ailments, is favoring the market growth. Various technological advancements, such as the development of CRISPR-Cas9 technology to cure hemoglobinopathies by editing, removing, adding, or altering genes and modifying the DNA, are providing an impetus to the market growth. In line with this, the widespread adoption of gene therapy for the treatment of hemoglobinopathy is favoring market growth. Other factors, such as the significant expansion in the healthcare industry, along with the implementation of various government initiatives to promote research and development (R&D) activities to introduce novel therapies for treating hemoglobinopathies at affordable costs is anticipated to provide a positive outlook for the market.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global hemoglobinopathies market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on type, treatment, test type and end user.
Breakup by Type:
Thalassemia
Alpha Thalassemia
Beta Thalassemia
Sickle Cell Disease
Others
Breakup by Treatment:
Blood Transfusion
Stem-cell Transplantation
Analgesics
Antibiotics
ACE Inhibitors
Hydroxyurea
Others
Breakup by Test Type:
Red Blood Cell (RBC) Count
Genetic Testing
High Performance Liquid Chromatography (HPLC)
Hemoglobin Isoelectric Focusing (Hb IEF)
Hemoglobin Electrophoresis (Hb ELP)
Hemoglobin Solubility Test
Breakup by End User:
Hospitals and Clinics
Diagnostics Laboratories
Others
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Bio-Rad Laboratories Inc., bluebird bio Inc., Bristol-Myers Squibb Company, Danaher Corporation, Emmaus Life Sciences Inc., Gamida-Cell Ltd., Global Blood Therapeutics Inc., Novartis AG, PerkinElmer Inc., Pfizer Inc., Prolong Pharmaceuticals LLC, Sangamo Therapeutics Inc. and Sysmex Corporation.
Key Questions Answered in This Report
1. What was the size of the global hemoglobinopathies market in 2022?
2. What is the expected growth rate of the global hemoglobinopathies market during 2023-2028?
3. What has been the impact of COVID-19 on the global hemoglobinopathies market?
4. What are the key factors driving the global hemoglobinopathies market?
5. What is the breakup of the global hemoglobinopathies market based on the type?
6. What is the breakup of the global hemoglobinopathies market based on the treatment?
7. What are the key regions in the global hemoglobinopathies market?
8. Who are the key players/companies in the global hemoglobinopathies market?
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Hemoglobinopathies Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Type
6.1 Thalassemia
6.1.1 Market Trends
6.1.2 Key Segments
6.1.2.1 Alpha Thalassemia
6.1.2.2 Beta Thalassemia
6.1.3 Market Forecast
6.2 Sickle Cell Disease
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Others
6.3.1 Market Trends
6.3.2 Market Forecast
7 Market Breakup by Treatment
7.1 Blood Transfusion
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Stem-cell Transplantation
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Analgesics
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Antibiotics
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 ACE Inhibitors
7.5.1 Market Trends
7.5.2 Market Forecast
7.6 Hydroxyurea
7.6.1 Market Trends
7.6.2 Market Forecast
7.7 Others
7.7.1 Market Trends
7.7.2 Market Forecast
8 Market Breakup by Test Type
8.1 Red Blood Cell (RBC) Count
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Genetic Testing
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 High Performance Liquid Chromatography (HPLC)
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Hemoglobin Isoelectric Focusing (Hb IEF)
8.4.1 Market Trends
8.4.2 Market Forecast
8.5 Hemoglobin Electrophoresis (Hb ELP)
8.5.1 Market Trends
8.5.2 Market Forecast
8.6 Hemoglobin Solubility Test
8.6.1 Market Trends
8.6.2 Market Forecast
9 Market Breakup by End User
9.1 Hospitals and Clinics
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Diagnostics Laboratories
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Others
9.3.1 Market Trends
9.3.2 Market Forecast
10 Market Breakup by Region
10.1 North America
10.1.1 United States
10.1.1.1 Market Trends
10.1.1.2 Market Forecast
10.1.2 Canada
10.1.2.1 Market Trends
10.1.2.2 Market Forecast
10.2 Asia-Pacific
10.2.1 China
10.2.1.1 Market Trends
10.2.1.2 Market Forecast
10.2.2 Japan
10.2.2.1 Market Trends
10.2.2.2 Market Forecast
10.2.3 India
10.2.3.1 Market Trends
10.2.3.2 Market Forecast
10.2.4 South Korea
10.2.4.1 Market Trends
10.2.4.2 Market Forecast
10.2.5 Australia
10.2.5.1 Market Trends
10.2.5.2 Market Forecast
10.2.6 Indonesia
10.2.6.1 Market Trends
10.2.6.2 Market Forecast
10.2.7 Others
10.2.7.1 Market Trends
10.2.7.2 Market Forecast
10.3 Europe
10.3.1 Germany
10.3.1.1 Market Trends
10.3.1.2 Market Forecast
10.3.2 France
10.3.2.1 Market Trends
10.3.2.2 Market Forecast
10.3.3 United Kingdom
10.3.3.1 Market Trends
10.3.3.2 Market Forecast
10.3.4 Italy
10.3.4.1 Market Trends
10.3.4.2 Market Forecast
10.3.5 Spain
10.3.5.1 Market Trends
10.3.5.2 Market Forecast
10.3.6 Russia
10.3.6.1 Market Trends
10.3.6.2 Market Forecast
10.3.7 Others
10.3.7.1 Market Trends
10.3.7.2 Market Forecast
10.4 Latin America
10.4.1 Brazil
10.4.1.1 Market Trends
10.4.1.2 Market Forecast
10.4.2 Mexico
10.4.2.1 Market Trends
10.4.2.2 Market Forecast
10.4.3 Others
10.4.3.1 Market Trends
10.4.3.2 Market Forecast
10.5 Middle East and Africa
10.5.1 Market Trends
10.5.2 Market Breakup by Country
10.5.3 Market Forecast
11 SWOT Analysis
11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats
12 Value Chain Analysis
13 Porters Five Forces Analysis
13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes
14 Price Analysis
15 Competitive Landscape
15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
15.3.1 Bio-Rad Laboratories Inc.
15.3.1.1 Company Overview
15.3.1.2 Product Portfolio
15.3.1.3 Financials
15.3.1.4 SWOT Analysis
15.3.2 bluebird bio Inc.
15.3.2.1 Company Overview
15.3.2.2 Product Portfolio
15.3.2.3 Financials
15.3.2.4 SWOT Analysis
15.3.3 Bristol-Myers Squibb Company
15.3.3.1 Company Overview
15.3.3.2 Product Portfolio
15.3.3.3 Financials
15.3.3.4 SWOT Analysis
15.3.4 Danaher Corporation
15.3.4.1 Company Overview
15.3.4.2 Product Portfolio
15.3.4.3 Financials
15.3.4.4 SWOT Analysis
15.3.5 Emmaus Life Sciences Inc.
15.3.5.1 Company Overview
15.3.5.2 Product Portfolio
15.3.5.3 Financials
15.3.6 Gamida-Cell Ltd.
15.3.6.1 Company Overview
15.3.6.2 Product Portfolio
15.3.6.3 Financials
15.3.7 Global Blood Therapeutics Inc.
15.3.7.1 Company Overview
15.3.7.2 Product Portfolio
15.3.7.3 Financials
15.3.8 Novartis AG
15.3.8.1 Company Overview
15.3.8.2 Product Portfolio
15.3.8.3 Financials
15.3.8.4 SWOT Analysis
15.3.9 PerkinElmer Inc.
15.3.9.1 Company Overview
15.3.9.2 Product Portfolio
15.3.9.3 Financials
15.3.9.4 SWOT Analysis
15.3.10 Pfizer Inc.
15.3.10.1 Company Overview
15.3.10.2 Product Portfolio
15.3.10.3 Financials
15.3.10.4 SWOT Analysis
15.3.11 Prolong Pharmaceuticals LLC
15.3.11.1 Company Overview
15.3.11.2 Product Portfolio
15.3.12 Sangamo Therapeutics Inc.
15.3.12.1 Company Overview
15.3.12.2 Product Portfolio
15.3.12.3 Financials
15.3.12.4 SWOT Analysis
15.3.13 Sysmex Corporation
15.3.13.1 Company Overview
15.3.13.2 Product Portfolio
15.3.13.3 Financials
15.3.13.4 SWOT Analysis
Figure 1: Global: Hemoglobinopathies Market: Major Drivers and Challenges
Figure 2: Global: Hemoglobinopathies Market: Sales Value (in Billion US$), 2017-2022
Figure 3: Global: Hemoglobinopathies Market Forecast: Sales Value (in Billion US$), 2023-2028
Figure 4: Global: Hemoglobinopathies Market: Breakup by Type (in %), 2022
Figure 5: Global: Hemoglobinopathies Market: Breakup by Treatment (in %), 2022
Figure 6: Global: Hemoglobinopathies Market: Breakup by Test Type (in %), 2022
Figure 7: Global: Hemoglobinopathies Market: Breakup by End User (in %), 2022
Figure 8: Global: Hemoglobinopathies Market: Breakup by Region (in %), 2022
Figure 9: Global: Hemoglobinopathies (Thalassemia) Market: Sales Value (in Million US$), 2017 & 2022
Figure 10: Global: Hemoglobinopathies (Thalassemia) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 11: Global: Hemoglobinopathies (Sickle Cell Disease) Market: Sales Value (in Million US$), 2017 & 2022
Figure 12: Global: Hemoglobinopathies (Sickle Cell Disease) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 13: Global: Hemoglobinopathies (Other Types) Market: Sales Value (in Million US$), 2017 & 2022
Figure 14: Global: Hemoglobinopathies (Other Types) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 15: Global: Hemoglobinopathies (Blood Transfusion) Market: Sales Value (in Million US$), 2017 & 2022
Figure 16: Global: Hemoglobinopathies (Blood Transfusion) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 17: Global: Hemoglobinopathies (Stem-cell Transplantation) Market: Sales Value (in Million US$), 2017 & 2022
Figure 18: Global: Hemoglobinopathies (Stem-cell Transplantation) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 19: Global: Hemoglobinopathies (Analgesics) Market: Sales Value (in Million US$), 2017 & 2022
Figure 20: Global: Hemoglobinopathies (Analgesics) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 21: Global: Hemoglobinopathies (Antibiotics) Market: Sales Value (in Million US$), 2017 & 2022
Figure 22: Global: Hemoglobinopathies (Antibiotics) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 23: Global: Hemoglobinopathies (ACE Inhibitors) Market: Sales Value (in Million US$), 2017 & 2022
Figure 24: Global: Hemoglobinopathies (ACE Inhibitors) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 25: Global: Hemoglobinopathies (Hydroxyurea) Market: Sales Value (in Million US$), 2017 & 2022
Figure 26: Global: Hemoglobinopathies (Hydroxyurea) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 27: Global: Hemoglobinopathies (Other Treatments) Market: Sales Value (in Million US$), 2017 & 2022
Figure 28: Global: Hemoglobinopathies (Other Treatments) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 29: Global: Hemoglobinopathies (Red Blood Cell (RBC) Count) Market: Sales Value (in Million US$), 2017 & 2022
Figure 30: Global: Hemoglobinopathies (Red Blood Cell (RBC) Count) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 31: Global: Hemoglobinopathies (Genetic Testing) Market: Sales Value (in Million US$), 2017 & 2022
Figure 32: Global: Hemoglobinopathies (Genetic Testing) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 33: Global: Hemoglobinopathies (High Performance Liquid Chromatography-HPLC) Market: Sales Value (in Million US$), 2017 & 2022
Figure 34: Global: Hemoglobinopathies (High Performance Liquid Chromatography-HPLC) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 35: Global: Hemoglobinopathies (Hemoglobin Isoelectric Focusing-Hb IEF) Market: Sales Value (in Million US$), 2017 & 2022
Figure 36: Global: Hemoglobinopathies (Hemoglobin Isoelectric Focusing-Hb IEF) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 37: Global: Hemoglobinopathies (Hemoglobin Electrophoresis-Hb ELP) Market: Sales Value (in Million US$), 2017 & 2022
Figure 38: Global: Hemoglobinopathies (Hemoglobin Electrophoresis-Hb ELP) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 39: Global: Hemoglobinopathies (Hemoglobin Solubility Test) Market: Sales Value (in Million US$), 2017 & 2022
Figure 40: Global: Hemoglobinopathies (Hemoglobin Solubility Test) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 41: Global: Hemoglobinopathies (Hospitals and Clinics) Market: Sales Value (in Million US$), 2017 & 2022
Figure 42: Global: Hemoglobinopathies (Hospitals and Clinics) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 43: Global: Hemoglobinopathies (Diagnostics Laboratories) Market: Sales Value (in Million US$), 2017 & 2022
Figure 44: Global: Hemoglobinopathies (Diagnostics Laboratories) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 45: Global: Hemoglobinopathies (Other End Users) Market: Sales Value (in Million US$), 2017 & 2022
Figure 46: Global: Hemoglobinopathies (Other End Users) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 47: North America: Hemoglobinopathies Market: Sales Value (in Million US$), 2017 & 2022
Figure 48: North America: Hemoglobinopathies Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 49: United States: Hemoglobinopathies Market: Sales Value (in Million US$), 2017 & 2022
Figure 50: United States: Hemoglobinopathies Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 51: Canada: Hemoglobinopathies Market: Sales Value (in Million US$), 2017 & 2022
Figure 52: Canada: Hemoglobinopathies Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 53: Asia-Pacific: Hemoglobinopathies Market: Sales Value (in Million US$), 2017 & 2022
Figure 54: Asia-Pacific: Hemoglobinopathies Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 55: China: Hemoglobinopathies Market: Sales Value (in Million US$), 2017 & 2022
Figure 56: China: Hemoglobinopathies Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 57: Japan: Hemoglobinopathies Market: Sales Value (in Million US$), 2017 & 2022
Figure 58: Japan: Hemoglobinopathies Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 59: India: Hemoglobinopathies Market: Sales Value (in Million US$), 2017 & 2022
Figure 60: India: Hemoglobinopathies Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 61: South Korea: Hemoglobinopathies Market: Sales Value (in Million US$), 2017 & 2022
Figure 62: South Korea: Hemoglobinopathies Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 63: Australia: Hemoglobinopathies Market: Sales Value (in Million US$), 2017 & 2022
Figure 64: Australia: Hemoglobinopathies Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 65: Indonesia: Hemoglobinopathies Market: Sales Value (in Million US$), 2017 & 2022
Figure 66: Indonesia: Hemoglobinopathies Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 67: Others: Hemoglobinopathies Market: Sales Value (in Million US$), 2017 & 2022
Figure 68: Others: Hemoglobinopathies Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 69: Europe: Hemoglobinopathies Market: Sales Value (in Million US$), 2017 & 2022
Figure 70: Europe: Hemoglobinopathies Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 71: Germany: Hemoglobinopathies Market: Sales Value (in Million US$), 2017 & 2022
Figure 72: Germany: Hemoglobinopathies Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 73: France: Hemoglobinopathies Market: Sales Value (in Million US$), 2017 & 2022
Figure 74: France: Hemoglobinopathies Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 75: United Kingdom: Hemoglobinopathies Market: Sales Value (in Million US$), 2017 & 2022
Figure 76: United Kingdom: Hemoglobinopathies Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 77: Italy: Hemoglobinopathies Market: Sales Value (in Million US$), 2017 & 2022
Figure 78: Italy: Hemoglobinopathies Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 79: Spain: Hemoglobinopathies Market: Sales Value (in Million US$), 2017 & 2022
Figure 80: Spain: Hemoglobinopathies Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 81: Russia: Hemoglobinopathies Market: Sales Value (in Million US$), 2017 & 2022
Figure 82: Russia: Hemoglobinopathies Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 83: Others: Hemoglobinopathies Market: Sales Value (in Million US$), 2017 & 2022
Figure 84: Others: Hemoglobinopathies Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 85: Latin America: Hemoglobinopathies Market: Sales Value (in Million US$), 2017 & 2022
Figure 86: Latin America: Hemoglobinopathies Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 87: Brazil: Hemoglobinopathies Market: Sales Value (in Million US$), 2017 & 2022
Figure 88: Brazil: Hemoglobinopathies Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 89: Mexico: Hemoglobinopathies Market: Sales Value (in Million US$), 2017 & 2022
Figure 90: Mexico: Hemoglobinopathies Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 91: Others: Hemoglobinopathies Market: Sales Value (in Million US$), 2017 & 2022
Figure 92: Others: Hemoglobinopathies Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 93: Middle East and Africa: Hemoglobinopathies Market: Sales Value (in Million US$), 2017 & 2022
Figure 94: Middle East and Africa: Hemoglobinopathies Market: Breakup by Country (in %), 2022
Figure 95: Middle East and Africa: Hemoglobinopathies Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 96: Global: Hemoglobinopathies Industry: SWOT Analysis
Figure 97: Global: Hemoglobinopathies Industry: Value Chain Analysis
Figure 98: Global: Hemoglobinopathies Industry: Porter's Five Forces Analysis
Table 1: Global: Hemoglobinopathies Market: Key Industry Highlights, 2022 and 2028
Table 2: Global: Hemoglobinopathies Market Forecast: Breakup by Type (in Million US$), 2023-2028
Table 3: Global: Hemoglobinopathies Market Forecast: Breakup by Treatment (in Million US$), 2023-2028
Table 4: Global: Hemoglobinopathies Market Forecast: Breakup by Test Type (in Million US$), 2023-2028
Table 5: Global: Hemoglobinopathies Market Forecast: Breakup by End User (in Million US$), 2023-2028
Table 6: Global: Hemoglobinopathies Market Forecast: Breakup by Region (in Million US$), 2023-2028
Table 7: Global: Hemoglobinopathies Market: Competitive Structure
Table 8: Global: Hemoglobinopathies Market: Key Players
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security